Cambrex Corp. (CBM) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts CBM Hot Sheet
Price: $59.99 --0%
Financial Fact:
Diluted (in share): 33M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Diluted (in share): 33M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cambrex Corp. (NYSE: CBM) reported Q2 EPS of $0.63, $0.19 better than the analyst estimate of $0.44. Revenue for the quarter came in at $106.4 million versus the consensus estimate of $110.03 million.
For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
